AMPK and cardiac remodelling
- 1 January 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Science China Life Sciences
- Vol. 61 (1), 14-23
- https://doi.org/10.1007/s11427-017-9197-5
Abstract
Cardiac remodelling is generally accepted as a critical process in the progression of heart failure. Myocyte hypertrophy, inflammatory responses and cardiac fibrosis are the main pathological changes associated with cardiac remodelling. AMP-activated protein kinase (AMPK) is known as an energy sensor and a regulator of cardiac metabolism under normal and ischaemic conditions. Additionally, AMPK has been shown to play roles in cardiac remodelling extending well beyond metabolic regulation. In this review, we discuss the currently defined roles of AMPK in cardiac remodelling and summarize the effects of AMPK on cardiac hypertrophy, inflammatory responses and fibrosis and the molecular mechanisms underlying these effects. In addition, we discuss some pharmacological activators of AMPK that are promising treatments for cardiac remodelling.This publication has 94 references indexed in Scilit:
- AMP-activated protein kinase, stress responses and cardiovascular diseasesClinical Science, 2012
- Site-specific Microtubule-associated Protein 4 Dephosphorylation Causes Microtubule Network Densification in Pressure Overload Cardiac HypertrophyPublished by Elsevier BV ,2010
- Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathwayCardiovascular Research, 2009
- AMPK and TNF- at the crossroad of cell survival and death in ischaemic heartCardiovascular Research, 2009
- AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic diseaseClinical Science, 2009
- SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1Published by Elsevier BV ,2008
- Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and AktPublished by Elsevier BV ,2008
- Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in VivoPublished by Elsevier BV ,2008
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007